Moses Goddard

Corporate Officer/Principal presso Semma Therapeutics, Inc.

Health Technology

Profilo

Moses Goddard is the founder of CytoSolv, Inc., a company founded in 2009.
He held the title of President, Secretary, Treasurer & Director at CytoSolv, Inc. Dr. Goddard is currently working as the Vice President-Surgery at Semma Therapeutics, Inc.

Posizioni attive di Moses Goddard

Società	Posizione	Inizio
Semma Therapeutics, Inc. Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	18/12/2018

Tutte le posizioni attive di Moses Goddard

Precedenti posizioni note di Moses Goddard

Società	Posizione	Fine
CytoSolv, Inc. CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI.	Fondatore	-

Vedi nel dettaglio l'esperienza di Moses Goddard

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Moses Goddard

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
CytoSolv, Inc. CytoSolv, Inc. Pharmaceuticals: OtherHealth Technology CytoSolv, Inc. develops proprietary technology to address wound healing. Its technology involves a mixture of wound-healing factors derived from porcine choroid plexus (CP), a key component of the blood brain barrier, which naturally secretes a variety of proteins into the cerebrospinal fluid responsible for growth, differentiation, nurturing and maintenance of the healing function. The company was founded by Moses Goddard and Christopher D. Thanos in 2009 and is headquartered in Providence, RI.	Health Technology
Semma Therapeutics, Inc. Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.	Health Technology